Introduction: Myocardial infarction (MI) therapy is one of the most common causes of death and health issue in the world, especially in developed countries. Thrombolytic administration is a preferred life saver method of acute MI if primary angioplasty is not possible. Given that the incidence of MI in patients with metabolic syndrome, so evaluation of therapeutic response to streptokinase in this regard is very important. Methods: In this descriptive analytical study, 340 acute coronary syndrome patients which have study inclusion criteria divided randomly in two groups (with and without metabolic syndrome each with 170 patients) and collected data analyzed by statistical methods using SPSS 20. Results: Pain improvement after treatment in the group without metabolic syndrome was significantly higher than another group (58.2% vs. 23.4%) (P = 0.001). ST-segment resolution at 90 min after treatment in the group without metabolic syndrome significantly higher than another group (P = 0.002). Conclusion: Results showed that using of angioplasty is recommended as the preferred method instead of thrombolytic treatment in patients with metabolic syndrome suffering from MI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.